CORRECTION article
Front. Immunol.
Sec. Antigen Presenting Cell Biology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1650718
Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
Provisionally accepted
- Hebei Medical University, Shijiazhuang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomicsXiaoting Lin 1,2,3,4, Guoyan Qi 1,2,3,4* and Peng Liu 1,2,3,41 Department of Oncology, Hebei Medical University, Shijiazhuang, Hebei, China 2Treatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, China 3 Hebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, Hebei, China 4 Hebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, Hebei, China* Correspondence: qiguoyan@hebmu.edu.cnKeywords: thymoma, myasthenia gravis, proteomics, prognostic, biomarkersCorrection on: Lin X, Qi G and Liu P (2025) Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics. Front. Immunol. 16:1580219. doi: 10.3389/fimmu.2025.1580219.Additional affiliation(s)In the published article, there was an error regarding the affiliations for Guoyan Qi. As well as having affiliations [1,3,4], she should also have [2 Treatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, China].The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Thymoma, Myasthenia Gravis, Proteomics, prognostic, biomarkers
Received: 20 Jun 2025; Accepted: 27 Jun 2025.
Copyright: © 2025 Lin, Qi and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Guoyan Qi, Hebei Medical University, Shijiazhuang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.